San
Francisco, 12 March, Liquid Biopsy Market Size, Share & Trends Analysis
Report By Application, By Sample Type (Blood, Urine) By Biomarker Type (CTC,
ctDNA, Exosomes), By Technology (NGS, PCR), By Region, And Segment Forecasts,
2018 - 2030
The global liquid biopsy market size is expected to reach USD 5.96 billion by
2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR
of 13.4% during the forecast period. Enhanced view of tumor provided by liquid
biopsy technology is estimated to augment the market in coming years.
While tissue
biopsies have been standard for cancer diagnosis for past several year, their
highly invasive nature and frequently associated complications have been major
concerns. Moreover, these biopsies lead to high expenditure being incurred by
patients. Liquid biopsies, on the other hand, offer a less invasive methodology
along with high effectiveness. Thus, there are a number of key private
organizations involved in rigorous R&D activities for liquid biopsy test
development and it is only a matter of time before these procedures grow in
prominence in diagnostic paraphernalia of oncologists and pathologists.
Access Full Research
Report On Liquid Biopsy Market Analysis:
Further key findings from the report suggest:
·
Technological developments such as electric
field induced release and measurement (EFIRM)- Liquid Biopsy (eLB), which
provides detection that can assist clinical treatment decisions for most common
subtype of cancers are expected to drive the uptake of saliva based sampling
over the forecast period
·
Currently, clinical use of isolation and
detection technology is limited to CTC quantitation but the number of CTCs is
found to hold significant correlation with disease severity. This is, thus,
estimated to augment the market over the coming years
·
Rising awareness regarding advantages of
multiple gene analysis along with the help of NGS is anticipated to support the
growth of the market
·
Organizations such as American Society of
Clinical Oncology (ASCO) are engaged in supporting implementation of liquid
biopsy, which in turn is likely to spur the growth of the market
·
Intensifying competition between biotech
companies and increasing investments by government in healthcare institutes
will lead to development of more sophisticated tests
·
Companies engaged in R&D and
commercialization of these products include Pathway Genomics; Natera Inc.; Epic
Sciences; Illumina; Foundation Medicine; Roche; LabCorp; and Sequenom
Browse More Reports Of This Category By
Grand View Research At: https://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global liquid biopsy marketon the basis of application, sample type, biomarker,
technology, and region:
Liquid
Biopsy Application Outlook (Revenue, USD Million, 2013 - 2030)
·
Therapy Selection for Metastatic Breast
Cancer (MBS)
·
Therapy Selection for Other Metastatic
Cancer
·
Molecular Health Monitoring
Liquid
Biopsy Sample Type Outlook (Revenue, USD Million, 2013 - 2030)
·
Blood Sample based
·
Urine Sample based
·
Other Bio Fluids (Tissue fluids and Saliva)
based
Liquid
Biopsy Biomarker Outlook (Revenue, USD Million, 2013 - 2030)
·
Circulating Tumor Cells (CTC)
·
Circulating Tumor DNA (ctDNA)
·
Exosomes
Liquid
Biopsy Technology Outlook (Revenue, USD Million, 2013 - 2030)
·
Multi-gene-parallel Analysis (NGS)
·
Single Gene Analysis (PCR Microarrays)
Liquid
Biopsy Regional Outlook (Revenue, USD Million, 2013 - 2030)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
MEA
o
South Africa
Browse Press
Release of this Report:
https://www.grandviewresearch.com/press-release/liquid-biopsy-market
https://www.grandviewresearch.com/press-release/liquid-biopsy-market
About Grand
View Research
Grand View Research provides syndicated as well as customized research
reports and consulting services on 46 industries across 25 major countries
worldwide. This U.S.-based market research and consulting company is registered
in California and headquartered in San Francisco. Comprising over 425 analysts
and consultants, the company adds 1200+ market research reports to its
extensive database each year. Supported by an interactive market intelligence
platform, the team at Grand View Research guides Fortune 500 companies and
prominent academic institutes in comprehending the global and regional business
environment and carefully identifying future opportunities.
For more
information: www.grandviewresearch.com/
No comments:
Post a Comment